MOLECULAR TARGETS IN THE NATIONAL-CANCER-INSTITUTE DRUG SCREEN

被引：43

作者：

BATES, SE ^{[1
]}

FOJO, AT ^{[1
]}

WEINSTEIN, JN ^{[1
]}

MYERS, TG ^{[1
]}

ALVAREZ, M ^{[1
]}

PAULI, KD ^{[1
]}

CHABNER, BA ^{[1
]}

机构：

[1] NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892

来源：

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1995年 / 121卷 / 9-10期

关键词：

D O I：

10.1007/BF01197759

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：495 / 500

页数：6

共 22 条

[1]

GENERATION OF A DRUG-RESISTANCE PROFILE BY QUANTITATION OF MDR-1/P-GLYCOPROTEIN IN THE CELL-LINES OF THE NATIONAL-CANCER-INSTITUTE ANTICANCER DRUG SCREEN [J].

ALVAREZ, M ;

PAULL, K ;

MONKS, A ;

HOSE, C ;

LEE, JS ;

WEINSTEIN, J ;

GREVER, M ;

BATES, S ;

FOJO, T .

JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2205-2214

[2]

BICKERS J, 1981, CANCER TREAT REP, V65, P427

[3]

BOYD MR, 1992, ANTITUMOR DRUG DISCO, P11

[4]

CHABNER BA, 1994, CANC TREATMENT UPDAT, P10

[5]

KEATING MJ, 1981, CANCER, V47, P2779, DOI 10.1002/1097-0142(19810615)47:12<2779::AID-CNCR2820471204>3.0.CO

[6]

2-0

[7]

RESPONSE TO SALVAGE THERAPY AND SURVIVAL AFTER RELAPSE IN ACUTE MYELOGENOUS LEUKEMIA [J].

KEATING, MJ ;

KANTARJIAN, H ;

SMITH, TL ;

ESTEY, E ;

WALTERS, R ;

ANDERSSON, B ;

BERAN, M ;

MCCREDIE, KB ;

FREIREICH, EJ .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (08) :1071-1080

[8]

KEATING MJ, 1981, BLOOD, V58, P584

[9]

DISCRIMINATION TECHNIQUES APPLIED TO THE NCI IN-VITRO ANTITUMOR DRUG SCREEN - PREDICTING BIOCHEMICAL-MECHANISM OF ACTION [J].

KOUTSOUKOS, AD ;

RUBINSTEIN, LV ;

FARAGGI, D ;

SIMON, RM ;

KALYANDRUG, S ;

WEINSTEIN, JN ;

KOHN, KW ;

PAULL, KD .

STATISTICS IN MEDICINE, 1994, 13 (5-7) :719-730

[10]

LEE JS, 1994, MOL PHARMACOL, V46, P627

← 1 2 3 →